netilmicin and Carcinoma--Bronchogenic

netilmicin has been researched along with Carcinoma--Bronchogenic* in 1 studies

Other Studies

1 other study(ies) available for netilmicin and Carcinoma--Bronchogenic

Article	Year
[Netilmicin in single daily doses for the bacterial bronchopulmonary complications in patients with advanced bronchogenic carcinoma]. La Clinica terapeutica, 1989, Sep-15, Volume: 130, Issue:5 In 40 patients with bacterial bronchopulmonary complications during polychemotherapy for advanced bronchogenic carcinoma, once-daily netilmicin (4.5 mg/kg every 24 h) brought about complete resolution of the infective process in 90% of the cases and eradication of the responsible pathogen in 82%. This result must be considered good in view of the patients' precarious condition due to their advanced neoplastic disease. Topics: Adult; Aged; Carcinoma, Bronchogenic; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Netilmicin; Respiratory Tract Infections	1989

Article

Year

[Netilmicin in single daily doses for the bacterial bronchopulmonary complications in patients with advanced bronchogenic carcinoma].

La Clinica terapeutica, 1989, Sep-15, Volume: 130, Issue:5

In 40 patients with bacterial bronchopulmonary complications during polychemotherapy for advanced bronchogenic carcinoma, once-daily netilmicin (4.5 mg/kg every 24 h) brought about complete resolution of the infective process in 90% of the cases and eradication of the responsible pathogen in 82%. This result must be considered good in view of the patients' precarious condition due to their advanced neoplastic disease.

Topics: Adult; Aged; Carcinoma, Bronchogenic; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Netilmicin; Respiratory Tract Infections

1989